Keyphrases
Approved Drugs
25%
Db Mouse
75%
Diabetes Prevention
25%
Drug Class
25%
Drug Efficacy
100%
Drug Response
25%
Efficacy Testing
25%
Embase
25%
Exenatide
25%
FDA-approved Drugs
25%
GLP-1 Receptor Agonist
25%
HbA1c Levels
25%
HbA1c Reduction
25%
Hemoglobin A1c (HbA1c)
25%
Human Response
25%
Inclusion Criteria
25%
Meta-analysis
100%
Minor Differences
25%
Model Selection
25%
Monotherapy
25%
PubMed
25%
Risk of Bias Assessment
25%
Standardized Mean Difference
25%
Surgical Intervention
25%
Systematic Meta-analysis
100%
Type 2 Diabetes Mellitus (T2DM)
100%
Type 2 Diabetes Prevention
25%
Zucker Rats
100%
Medicine and Dentistry
Arm
33%
Diabetes Prevention
33%
Drug Efficacy
100%
Drug Response
33%
Effect Size
100%
Exenatide
33%
Glucagon-Like Peptide-1 Agonist
33%
Hemoglobin A1c
100%
Maturity Onset Diabetes of the Young
100%
Meta-Analysis
100%
Monotherapy
33%
Surgery
33%
Systematic Review
100%
Pharmacology, Toxicology and Pharmaceutical Science
Db/Db Mouse
75%
Exendin 4
25%
Glucagon Like Peptide 1 Receptor Agonist
25%
Hemoglobin A1c
75%
Monotherapy
25%
Non Insulin Dependent Diabetes Mellitus
100%
Zucker Diabetic Fatty Rat
100%
Neuroscience
Exenatide
33%
Glucagon-Like Peptide-1 Agonist
33%
Hemoglobin A1c
100%
Meta-Analysis
100%
Qualitative Research
33%